Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.917 USD | -0.64% | -5.10% | -34.46% |
Mar. 27 | Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating | MT |
Mar. 27 | Wedbush Adjusts bluebird bio's PT to $1.72 From $1.68, Maintains Neutral Rating | MT |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.